Copyright
©The Author(s) 2021.
World J Virol. Sep 25, 2021; 10(5): 275-287
Published online Sep 25, 2021. doi: 10.5501/wjv.v10.i5.275
Published online Sep 25, 2021. doi: 10.5501/wjv.v10.i5.275
Figure 1
PRISMA flow diagram.
Figure 2 Prevalence of coronavirus disease 2019 associated new onset diabetes mellitus.
COVID-19: Coronavirus disease 2019; DM: Diabetes mellitus.
Figure 3 Prevalence of coronavirus disease 2019 associated hyperglycemia.
COVID-19: Coronavirus disease 2019.
Figure 4 Mortality among coronavirus disease 2019 cases with subgroup analysis based on their diabetes status.
COVID-19: Coronavirus disease 2019; DM: Diabetes mellitus.
Figure 5 Occurrence of adverse events among coronavirus disease 2019 cases with subgroup analysis based on their diabetes status.
COVID-19: Coronavirus disease 2019; DM: Diabetes mellitus; ICU: Intensive care unit.
Figure 6
Meta regression of diabetes status and mortality.
- Citation: Shrestha DB, Budhathoki P, Raut S, Adhikari S, Ghimire P, Thapaliya S, Rabaan AA, Karki BJ. New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis. World J Virol 2021; 10(5): 275-287
- URL: https://www.wjgnet.com/2220-3249/full/v10/i5/275.htm
- DOI: https://dx.doi.org/10.5501/wjv.v10.i5.275